Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Lexaria Bioscience Corp. - Warrant (NQ:LEXXW)

0.0501 -0.0199 (-28.43%)

Streaming Delayed Price Updated: 10:09 AM EST, Nov 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	7,401
Open	0.0500
Bid (Size)	0.0500 (4,100)
Ask (Size)	0.0606 (100)
Prev. Close	0.0700
Today's Range	0.0500 - 0.0624
52wk Range	0.0180 - 1.310
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

November 12, 2025

Via ACCESS Newswire

Lexaria Bioscience Corp. Provides Strategic Update

October 09, 2025

Via ACCESS Newswire

Performance

YTD	-93.7%	-93.7%
1 Month	+29.1%	+29.1%
3 Month	-44.4%	-44.4%
6 Month	-72.2%	-72.2%
1 Year	-93.7%	-93.7%

More News

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

September 29, 2025

Via ACCESS Newswire

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

September 26, 2025

Via ACCESS Newswire

Lexaria Attending BIO International Convention

June 05, 2025

Via ACCESS Newswire

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

February 27, 2025

Via ACCESS Newswire

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

September 19, 2025

Via ACCESS Newswire

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference

August 27, 2025

Via ACCESS Newswire

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

August 14, 2025

Via ACCESS Newswire

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

August 06, 2025

Via ACCESS Newswire

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

July 28, 2025

Via ACCESS Newswire

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

February 24, 2025

Via ACCESS Newswire

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

February 20, 2025

Via ACCESS Newswire

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

February 11, 2025

Via ACCESS Newswire

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

July 23, 2025

Via ACCESS Newswire

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

June 23, 2025

Via ACCESS Newswire

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

June 11, 2025

Via ACCESS Newswire

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

May 12, 2025

Via ACCESS Newswire

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

April 28, 2025

Via ACCESS Newswire

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

February 06, 2025

Via ACCESS Newswire

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

April 25, 2025

Via ACCESS Newswire

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology

April 23, 2025

Via ACCESS Newswire

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

April 03, 2025

Via ACCESS Newswire

Lexaria's Human GLP-1 Study #5 Begins Dosing

April 02, 2025

Via ACCESS Newswire

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)

March 18, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Warrant publicly traded?

Yes, Lexaria Bioscience Corp. - Warrant is publicly traded.

What exchange does Lexaria Bioscience Corp. - Warrant trade on?

Lexaria Bioscience Corp. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Lexaria Bioscience Corp. - Warrant?

The ticker symbol for Lexaria Bioscience Corp. - Warrant is LEXXW on the Nasdaq Stock Market

What is the current price of Lexaria Bioscience Corp. - Warrant?

The current price of Lexaria Bioscience Corp. - Warrant is 0.0501

When was Lexaria Bioscience Corp. - Warrant last traded?

The last trade of Lexaria Bioscience Corp. - Warrant was at 11/14/25 10:09 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.